PolyXen 平台 :PolyXen是蛋白质和肽药物输送的使能平台技术。它使用生物聚合物聚唾液酸(PSA)来延长药物的半衰期,并可能提高治疗肽和蛋白质的稳定性。附着部位和PSA链的长度都可以通过改变分子的表观流体力学半径来影...查看全文
牛股小红书2022-04-28 13:48
$Xenetic Biosciences(XBIO)$ 与CLS Therapeutics签署了独家许可和再许可协议,以开发其基于DNA酶的介入性肿瘤学平台,旨在改善现有治疗,包括免疫疗法。
根据协议,Xenetic拥有CLS知识产权的独家许可证,用于在癌症中使用DNA酶,包括DNA酶与标准疗法(包括化疗、放疗和检查点抑制剂)的系统联...查看全文
$Xenetic Biosciences(XBIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013384 Act: 34 Size: 86 KB 网页链接
$Xenetic Biosciences(XBIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-20-000308 Act: 34 Size: 66 KB 网页链接
$Xenetic Biosciences(XBIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001535610-20-000031 Act: 34 Size: 13 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-19-003921 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-19-003923 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-19-003919 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-19-003915 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-19-003917 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-19-003911 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-19-003913 Size: 5 KB 网页链接